The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale
Abstract
The Sheehan Disability Scale (SDS) is a patient-rated, discretized analog measure of functional disability in work, social, and family life. Its increasing use in clinical trials in psychiatry suggests a need to assess its responsiveness and interpretability. In this paper we identify and review studies in which the SDS was used as a treatment outcome measure. Our objectives are (i) to evaluate the sensitivity of the SDS to treatment effects and (ii) to examine potential thresholds or cutoff scores for remission and response. Studies for the review were retrieved from the National Library of Medicine's PubMed database (1966 to 21 March 2007) and other sources. All studies had to use the SDS, be double-blind, controlled or large open-label trials in English. Studies assessing nonpharmacological treatments, long-term trials (>12 weeks), small n trials (less than 20 patients per treatment arm) and trials for conditions other than one of the anxiety disorders, depression, or premenstrual dysphoric disorder were excluded. Extracted data included the diagnostic target of treatment, n, study design, and method of analysis. Initial, endpoint and/or mean change scores were extracted from tables, text, or extrapolated from figures. In all, 37 studies meeting the inclusion criteria were retrieved and reviewed. All of the studies treated the SDS as a numeric scale and analyzed mean change or endpoint differences with parametric statistics. Three provided additional outcome data using nonparametric response or remission criteria. Overall, the SDS performed well in discriminating between active and inactive treatments. The results indicate that the SDS is sensitive to treatment effects. To establish reliable and valid cutoff scores for remission and response, there is a need to supplement parametric analyses using mean change and endpoint differences with nonparametric analyses showing the percentage meeting specified response and remission criteria. In addition, the percentages with endpoint scores of zero should be reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982 · cited 2×
“…Adjustment Scale (SAS) consisted of over 50 items (Weissman and Bothwell, 1976) whereas the Medical Outcome Study (MOS) SF-36 had 36 items (Ware and Sherbourne, 1992) and the Global Assessment Scale required differentiating among 21 items to produce a score from 0 to 100 (Endicott et al., 1976).”
MethodJaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
The functioning and well-being of depressed patients. Results from the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.262.7.914 · Cited by 2,808
The Work and Social Adjustment Scale: a simple measure of impairment in functioning
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.461 · Cited by 2,515
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
The Functioning and Well-being of Depressed Patients: Results From the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.1989.03430070062031 · Cited by 2,130 · cited 1×
“Patients with major depression, for example, are known to have increased rates of impaired occupational functioning, marital problems, and social isolation (Wells et al., 1989; Broadhead et al., 1990; Olfson et al., 1997).”
BackgroundFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 2×
“Remission, which is viewed as the optimal outcome (Keller, 2003), is usually defined as a state of minimal to no symptoms and a return to normal functioning (Frank et al., 1991).”
Background(1993) · PubMed · Cited by 1,900
Measuring change over time: Assessing the usefulness of evaluative instruments
Guyatt, G., Walter, S., & Norman, G. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90069-5 · Cited by 1,880
Determining a minimal important change in a disease-specific quality of life questionnaire
JUNIPER, E. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90036-1 · Cited by 1,824
Assessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Self-citationDeyo, R. A., Diehr, P., & Patrick, D. L. (1991) · Controlled Clinical Trials · doi:10.1016/s0197-2456(05)80019-4 · Cited by 1,364
Depression, Disability Days, and Days Lost From Work in a Prospective Epidemiologic Survey
Broadhead, W. E. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450190056028 · Cited by 1,237
Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997) · The International Journal of Psychiatry in Medicine · doi:10.2190/t8em-c8yh-373n-1uwd · Cited by 987 · cited 3×
“One convention, on the basis of the data from Leon et al. (1997) in a primary care sample, is that a total SDS score of < 5 signifies remission.”
BackgroundMethodInfluentialSelf-citationPost-traumatic stress disorder in the community: an epidemiological study
Davidson, J. R. T., Hughes, D., Blazer, D. G., & George, L. K. (1991) · Psychological Medicine · doi:10.1017/s0033291700022352 · Cited by 969
Comparisons of Five Health Status Instruments for Orthopedic Evaluation
Liang, M. H., Fossel, A. H., & Larson, M. G. (1990) · Medical Care · doi:10.1097/00005650-199007000-00008 · Cited by 914
The Optimal Number of Response Alternatives for a Scale: A Review
Cox, E. P. (1980) · Journal of Marketing Research · doi:10.1177/002224378001700401 · Cited by 811
Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., & Walters, E. E. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.415 · Cited by 795
Past-Year Use of Outpatient Services for Psychiatric Problems in the National Comorbidity Survey
Kessler, R. C., Zhao, S., Katz, S. J., Kouzis, A. C., Frank, R. G., Edlund, M., & Leaf, P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.115 · Cited by 610
Liang, M. H., Larson, M. G., Cullen, K. E., & Schwartz, J. A. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280513 · Cited by 588
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Treatments of Depression and the Functional Capacity to Work
Mintz, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100005001 · Cited by 563
Kessler, R. C., DuPont, R. L., Berglund, P., & Wittchen, H.-U. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1915 · Cited by 486
Quality of Life in Panic Disorder
Markowitz, J. S. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110026004 · Cited by 468
Middel, B., & Van Sonderen, E. (2002) · International Journal of Integrated Care · doi:10.5334/ijic.65 · Cited by 464
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1982 · Cited by 432
Treating Major Depression in Primary Care Practice: Eight-Month Clinical Outcomes
Schulberg, H. C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100061008 · Cited by 426
Rating Scales: Numeric Values May Change the Meaning of Scale Labels
Schwarz, N., Knauper, B., Hippler, H.-J., Noelle-Neumann, E., & Clark, L. (1991) · Public Opinion Quarterly · doi:10.1086/269282 · Cited by 411
Mental Disorders and Disability Among Patients in a Primary Care Group Practice
Olfson, M., Fireman, B., Weissman, M. M., Leon, A. C., Sheehan, D. V., Kathol, R. G., Hoven, C., & Farber, L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1734 · Cited by 400
Self-citationKeller, M. B. (2003) · JAMA · doi:10.1001/jama.289.23.3152 · Cited by 388
Size and burden of social phobia in Europe
Fehm, L., Pelissolo, A., Furmark, T., & Wittchen, H.-U. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.002 · Cited by 373
Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998) · JAMA · doi:10.1001/jama.280.8.708 · Cited by 348
The social costs of anxiety disorders
Leon, A. C., Portera, L., & Weissman, M. M. (1995) · British Journal of Psychiatry · doi:10.1192/s0007125000293355 · Cited by 335 · cited 1×
“Significant impairment in functioning has also been observed in patients with anxiety disorders including generalized anxiety (Leon et al., 1995, Olfson et al., 1997; Kessler et al., 1999), panic disorder (PD) (Markowitz et al., 1989; Hollifield et al., 1997; Marcus et al., 1997), social anxiety…”
BackgroundRandomized Trial of a Depression Management Program in High Utilizers of Medical Care
Katzelnick, D. J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.4.345 · Cited by 331
Tucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., & Pitts, C. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1105 · Cited by 324
Assessing impairment in patients with panic disorder: the Sheehan Disability Scale
Leon, A. C., Shear, M. K., Portera, L., & Klerman, G. L. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788510 · Cited by 319
Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 282
Treatment Effects on the Social Adjustment of Depressed Patients
Weissman, M. M. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760120033006 · Cited by 281
Noel, P. H. (2004) · The Annals of Family Medicine · doi:10.1370/afm.143 · Cited by 267
Prevalence of Anxiety, Depression, and Substance Use Disorders in an Urban General Medicine Practice
Olfson, M. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.9.876 · Cited by 267
Stein, M. B., Fyer, A. J., Davidson, J. R. T., Pollack, M. H., & Wiita, B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.756 · Cited by 262
An Additional Basic Science for Clinical Medicine: IV. The Development of Clinimetrics
FEINSTEIN, A. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-6-843 · Cited by 257
Baldwin, D., Bobes, J., Stein, D. J., Scharwächter, I., & Faure, M. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.2.120 · Cited by 251
Pollack, M. H., Zaninelli, R., Goddard, A., McCafferty, J. P., Bellew, K. M., Burnham, D. B., & Iyengar, M. K. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0508 · Cited by 246
Hirschfeld, R. M. A., Dunner, D. L., Keitner, G., Klein, D. N., Koran, L. M., Kornstein, S. G., Markowitz, J. C., Miller, I., Nemeroff, C. B., Ninan, P. T., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01291-4 · Cited by 231 · cited 1×
“In addition, there is good evidence that remission and response in disability and impairment lag well behind remission and response in the symptoms of psychiatric disorders (Hirschfeld et al., 2002).”
BackgroundDouble-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder
Ballenger, J. C., Wheadon, D. E., Steiner, M., Bushnell, W., & Gergel, I. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.36 · Cited by 220
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder
Davidson, J. R. T., Payne, V. M., Connor, K. M., Foa, E. B., Rothbaum, B. O., Hertzberg, M. A., & Weisler, R. H. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00009 · Cited by 216 · cited 4×
“Table 1 Database used for review of SDS Author Active medication (s) Duration (weeks) Design n PD Hoehn-Saric et al. (1993) Fluvoxamine flexible dose Eight weeks DBPC 36 Sheehan et al. (1993) Alprazolam flexible dose 1.5–10 mg/day; buspirone 15–100 mg/day Eight weeks DBPC 92 Michelson et al. (1998) Fluoxetine fixed do…”
BackgroundResultInfluentialHerbert, J. D., Gaudiano, B. A., Rheingold, A. A., Myers, V. H., Dalrymple, K., & Nolan, E. M. (2005) · Behavior Therapy · doi:10.1016/s0005-7894(05)80061-9 · Cited by 203
Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., & Sheehan, D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.749 · Cited by 198
Self-citationClinical guidelines for establishing remission in patients with depression and anxiety.
Ballenger, J. C. (1999) · PubMed · Cited by 191
Montgomery, S. A., Kasper, S., Stein, D. J., Hedegaard, K. B., & Lemming, O. M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200103000-00002 · Cited by 187
Evaluating measurement responsiveness.
Liang, M. H. (1995) · PubMed · Cited by 176
Lader, M., Stender, K., Bürger, V., & Nil, R. (2004) · Depression and Anxiety · doi:10.1002/da.20014 · Cited by 163
A Neural Model of Memory Impairment in Diffuse Cerebral Atrophy
Ruppin, E., & Reggia, J. A. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.1.19 · Cited by 142
Versiani, M., Cassano, G. B., Perugi, G., Benedetti, A., Mastalli, L., Nardi, A. E., & Savino, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0107 · Cited by 140
Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder
Lecrubier, Y., Judge, R., & The Collaborative Paroxetine Panic Study Investigators (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00389.x · Cited by 139
A European perspective on social anxiety disorder
Lecrubier, Y., Wïttchen, H., Faravelli, C., Bobes, J., Patel, A. K., & Knapp, M. R. J. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00216-9 · Cited by 139
Panic disorder and quality of life: variables predictive of functional impairment
Hollifield, M. A., Katon, W. J., SKIPPER, B. J., Chapman, T., Ballenger, J. C., Mannuzza, S., & Fyer, A. J. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.766 · Cited by 130
Escitalopram in the treatment of social anxiety disorder
Kasper, S. F., Stein, D. J., Loft, H., & Nil, R. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.3.222 · Cited by 127
Michelson, D., Lydiard, R. B., Pollack, M. H., Tamura, R., HOOG, S. L., Tepner, R. G., Demitrack, M. A., Tollefson, G. D., & the Fluoxetine Panic Disorder Study Group (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1570 · Cited by 123
A method of measuring psychological changes specific to the individual psychiatric patient*
Shapiro, M. B. (1961) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1961.tb00940.x · Cited by 122
Liebowitz, M. R., Stein, M. B., Tancer, M. E., Carpenter, D. J., Oakes, R., & Pitts, C. D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0113 · Cited by 117
Effect of Fluvoxamine on Panic Disorder
Hoehn‐Saric, R., McLeod, D. R., & Hipsley, P. A. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00004 · Cited by 108
Determinants of Scale Response: Label versus Position
Wildt, A. R., & Mazis, M. B. (1978) · Journal of Marketing Research · doi:10.1177/002224377801500209 · Cited by 105
Smeraldi, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00139-0 · Cited by 104
Rickels, K., Mangano, R. M., & Khan, A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138764.31106.60 · Cited by 98
Landén, M., Nissbrandt, H., Allgulander, C., Sörvik, K., Ysander, C., & Eriksson, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301216 · Cited by 96
New approaches to managing difficult-to-treat depressions.
Thase, M. E. (2003) · PubMed · Cited by 94
Sheehan, D. V., Raj, A. B., Harnett-Sheehan, K., Soto, S., & Knapp, E. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03405.x · Cited by 86
Self-citationAsnis, G. M., Hameedi, F. A., Goddard, A. W., Potkin, S. G., Black, D. W., Jameel, M., Desagani, K., & Woods, S. W. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00265-7 · Cited by 79
Open Trial of Psychodynamic Psychotherapy for Panic Disorder: A Pilot Study
Milrod, B. L., Busch, F., Leon, A. C., Shapiro, T., Aronson, A. C., Roiphe, J., Rudden, M. G., Singer, M. B., Goldman, H., Richter, D., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1878 · Cited by 78
Cohen, L. S., Soares, C. N., Yonkers, K. A., Bellew, K. M., Bridges, I. M., & Steiner, M. S. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000140005.94790.9c · Cited by 73
Modern Psychometrics in Clinimetrics: Impact on Clinical Trials of Antidepressants
Bech, P. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076448 · Cited by 73
Westenberg, H. G. M., Stein, D. J., Yang, H., Li, D., & Barbato, L. M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104906.75206.8b · Cited by 73
Fluvoxamine-Controlled Release Formulation for the Treatment of Generalized Social Anxiety Disorder
Davidson, J. R. T., Yaryura-Tobias, J. A., DuPont, R. L., Stallings, L., Barbato, L. M., van der Hoop, R. G., & Li, D. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000106222.36344.96 · Cited by 69
Faravelli, C. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076449 · Cited by 65
A staging approach to measuring patient‐centred subjective outcomes*
Bilsbury, C. D., & Richman, A. (2002) · Acta Psychiatrica Scandinavica · doi:10.1046/j.0001-690x.2002.00052.x · Cited by 61
Stein, D. J., Davidson, J. R. T., Seedat, S., & Beebe, K. L. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1829 · Cited by 61
Psychopharmacology: Number Needed to Treat: An Underused Measure of Treatment Effect
Pinson, L. A., & Gray, G. E. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.2.145 · Cited by 57
Lecrubier, Y. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.106.s415.2.x · Cited by 56
Freeman, E. W., Sondheimer, S. J., Sammel, M. D., Ferdousi, T., & Lin, H. Y. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0616 · Cited by 53
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo
Keller, M. B., Lavori, P. W., Goldenberg, I. M., Baker, L. A., Pollack, M. H., Sachs, G. S., Rosenbaum, J. F., Deltito, J. A., Leon, A. C., Shear, K. M., et al. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90074-t · Cited by 42
Self-Reported Anxiety, General Medical Conditions, and Disability Bed Days
Marcus, S. C., Olfson, M., Pincus, H. A., Shear, M. K., & Zarin, D. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1766 · Cited by 36
Escitalopram in clinical practice: Results of an open-label trial in a naturalistic setting
Rush, A. J., & Bose, A. (2005) · Depression and Anxiety · doi:10.1002/da.20051 · Cited by 35
Monoamine Oxidase Inhibitors and Alprazolam in the Treatment of Panic Disorder and Agoraphobia
Sheehan, D. V. (1985) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30708-1 · Cited by 27
Self-citationCognitive‐Behavioral group treatment for panic disorder with agoraphobia
Galassi, F., Quercioli, S., Charismas, D., Niccolai, V., & Barciulli, E. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20358 · Cited by 26
MAOI treatment response: multiaxial assessment
Giller, E. L., Bialos, D., Riddle, M. A., & Waldo, M. C. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90060-2 · Cited by 18
Clinician perspective on achieving and maintaining remission in depression.
Kelsey, J. E. (2001) · PubMed · Cited by 15
Efficacy of Paroxetine for Relapse Prevention in Social Anxiety Disorder: A 24-Week Study
Stein, D. J., Versiani, M., Hair, T., & Kumar, R. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1111
Cited by
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
The Use and Effectiveness of Mobile Apps for Depression: Results From a Fully Remote Clinical Trial
Arean, P. A., Hallgren, K. A., Jordan, J. T., Gazzaley, A., Atkins, D. C., Heagerty, P. J., & Anguera, J. A. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.6482 · Cited by 376
McKnight, P. E., & Kashdan, T. B. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.005 · Cited by 400
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers
Havervall, S., Rosell, A., Phillipson, M., Mangsbo, S. M., Nilsson, P., Hober, S., & Thålin, C. (2021) · JAMA · doi:10.1001/jama.2021.5612 · Cited by 388
Etzelmueller, A., Vis, C., Karyotaki, E., Baumeister, H., Titov, N., Berking, M., Cuijpers, P., Riper, H., & Ebert, D. D. (2020) · Journal of Medical Internet Research · doi:10.2196/18100 · Cited by 356
Metadata
- Authors
- Sheehan, K. H., & Sheehan, D. V.
- Venue
- International Clinical Psychopharmacology
- Published
- 2008-03
- Volume
- 23
- Issue
- 2
- Pages
- 70-83
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2084779737
- Cited by
- 467
- References
- 96
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.